Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

Skin Alterations Associated With Atopic Dermatitis Clinical Trial

Official title: Randomisierte, Doppelblinde, Plazebo-kontrollierte Prüfung Zum Nachweis Der Wirksamkeit Und Der Lokalen Verträglichkeit Einer 2%Igen Sertaconazol-Crème Bei Patienten Mit Atopischer Dermatitis (Abridged)

Status Completed

Clinical Trial Summary

Investigation aimed to explore the efficacy of a topical Sertaconazole cream 2% in patients with skin alterations associated with atopic dermatitis

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Dermatitis
• Dermatitis, Atopic
• Eczema
• Skin Alterations Associated With Atopic Dermatitis

• NCT number: NCT01792713
• Study type: Interventional
• Source: Spirig Pharma Ltd.
• Status: Completed
• Phase: Phase 2
• Start date: February 2013
• Completion date: February 2014